PAULSON & CO. INC. Historic Quarter Change: USA Other Stocks, Reduced

PAULSON & CO. INC. historic quarter change: USA Other Stocks, Reduced

In shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), over 23 quarters from 2013-06-30 to 2026-06-30, PAULSON & CO. INC. opened 126 positions, added to 86, reduced 117 and sold out of 129.

Q3 2016: Stock MYLAN NV; Country of operation —; Class SHS EURO; Shares before 22,028,061.
Q3 2016: Stock VALEANT PHARMACEUTICALS INTE; Country of operation —; Class COM; Shares before 19,072,000.
Q3 2016: Stock MALLINCKRODT PLC; Country of operation —; Class SHS; Shares before 8,371,080.
Q3 2016: Stock SYNERGY PHARMACEUTICALS INC; Country of operation United States; Class COM NEW; Shares before 27,756,668.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1035674), 23 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-14); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-15); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-17); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-14); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-15); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-14); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-14); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-15); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-15); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-16); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-16); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-17); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-14); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2001-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).

Quarter	Stock	Country of operation	Class	Shares before	Shares after	Share change	Value before	Value after	Value change	Filed
Q3 2016	MYLAN NV CUSIP N59465109		SHS EURO	22,028,061	21,811,661	-216,400	$952,493,000	$831,461,000	-$121,032,000	2016-11-14
Q3 2016	VALEANT PHARMACEUTICALS INTE CUSIP 91911K102		COM	19,072,000	18,871,000	-201,000	$384,110,000	$463,283,000	+$79,173,000	2016-11-14
Q3 2016	MALLINCKRODT PLC CUSIP G5785G107		SHS	8,371,080	7,974,472	-396,608	$508,794,000	$556,459,000	+$47,665,000	2016-11-14
Q3 2016	SYNERGY PHARMACEUTICALS INC CUSIP 871639308	United States	COM NEW	27,756,668	24,228,655	-3,528,013	$105,475,000	$133,500,000	+$28,025,000	2016-11-14
Q3 2016	VMWARE INC-CLASS A CUSIP 928563402	United States	CL A COM	1,972,100	1,914,015	-58,085	$112,844,000	$140,393,000	+$27,549,000	2016-11-14
Q3 2016	ENDO INTERNATIONAL PLC CUSIP G30401106		SHS	8,956,300	7,953,900	-1,002,400	$139,629,000	$160,271,000	+$20,642,000	2016-11-14
Q3 2016	ALLERGAN PLC CUSIP G0177J108		SHS	3,948,451	3,891,134	-57,317	$912,448,000	$896,167,000	-$16,281,000	2016-11-14
Q3 2016	CAESARS ACQUISITION CO-CL A CUSIP 12768T103		CL A	13,141,098	13,117,998	-23,100	$147,443,000	$162,926,000	+$15,483,000	2016-11-14
Q3 2016	COBALT INTERNATIONAL ENERGY CUSIP 19075F106		COM	39,096,300	31,218,927	-7,877,373	$52,389,000	$38,711,000	-$13,678,000	2016-11-14
Q3 2016	AKORN INC CUSIP 009728106		COM	9,012,900	8,974,400	-38,500	$256,732,000	$244,642,000	-$12,090,000	2016-11-14
Q3 2016	OASIS PETROLEUM INC CUSIP 674215108		COM	5,287,167	5,208,100	-79,067	$49,382,000	$59,737,000	+$10,355,000	2016-11-14
Q3 2016	ENZYMOTEC LTD CUSIP M4059L101		SHS	4,224,139	4,205,980	-18,159	$35,314,000	$29,442,000	-$5,872,000	2016-11-14
Q3 2016	CAESARS ENTERTAINMENT CORP CUSIP 127686103		COM	14,441,000	14,417,900	-23,100	$111,051,000	$107,413,000	-$3,638,000	2016-11-14
Q3 2016	ACTIVISION BLIZZARD INC CUSIP 00507V109	United States	COM	1,000,000	974,200	-25,800	$39,630,000	$43,157,000	+$3,527,000	2016-11-14
Q3 2016	ALEXION PHARMACEUTICALS INC CUSIP 015351109		COM	268,000	227,700	-40,300	$31,292,000	$27,902,000	-$3,390,000	2016-11-14
Q3 2016	OFFICE DEPOT INC CUSIP 676220106		COM	15,709,757	15,370,657	-339,100	$51,999,000	$54,873,000	+$2,874,000	2016-11-14
Q3 2016	FELCOR LODGING TRUST INC CUSIP 31430F101		COM	950,000	500,000	-450,000	$5,919,000	$3,215,000	-$2,704,000	2016-11-14
Q3 2016	RIGEL PHARMACEUTICALS INC CUSIP 766559603	United States	COM NEW	999,700	805,000	-194,700	$2,229,000	$2,954,000	+$725,000	2016-11-14

Similar Firms

Firm Name	Country	13F Value	Holdings
TREMBLANT CAPITAL GROUP	United States	$3.107B	57
Cevian Capital II GP LTD	Jersey	$3.118B	3
Krilogy Financial LLC	United States	$3.105B	990
AXXCESS WEALTH MANAGEMENT, LLC	United States	$3.120B	373
DeepCurrents Investment Group LLC	United States	$3.121B	267
Wedmont Private Capital	United States	$3.101B	838
EULAV Asset Management	United States	$3.124B	133
Larson Financial Group LLC	United States	$3.132B	3,700
Cohen Klingenstein LLC	United States	$3.090B	205
DONALDSON CAPITAL MANAGEMENT, LLC	United States	$3.090B	235